Reddit Posts
APES~SAVE THE BOOBIES! Lets SQUEEZE ICCM. The stock grinded higher today and popped going into the close on higher volume. News in the AM?
ICCM gearing up for giga squeeze. Breast cancer breakthrough.
ICCM Stock Runs Up Huge Gains On Positive Kidney Lesion Treatment
💰💰💰Good morning! #premarket #watchlist 12/20 $ICCM -IceCure's ProSense Safe and Effective in Treating Kidney Tumors with 89.5% Recurrence-Free Rate(+200%), $XCUR -13D form. big buys(+50%), $VRNA -Announces Ensifentrine Meets Primary and Key Secondary Endpoints in Phase 3 ENHANCE-1 Trial(+38%)
Wondering if anyone was able to get on ICCM today?
ICCM 💛Breast cancer sucks and so does the shorts
💰💰💰Good morning! #premarket #watchlist 11/8 $ICCM -ProSense® Achieves Significant Milestone in Medicare Coverage of Breast Cancer Procedures, $HIMS -earnings, $RIDE -Gains on $170 Million Foxconn Investment Deal
Mentions
ICCM …..a cancer breast doctor I trust swears by this procedure. Her effectiveness rate is incredible. I loaded up.
I’ve been holding ICCM and its imminent FDA approval for around 2 years. Don’t expect this to happen overnight is all I’m saying.
Holding my ICCM with -12% and hoping for a better future.
Today’s buys: IINN - 1500 shares @ $0.906 ICCM - 1500 shares @ $1.4697 BCTX - 500 shares @ $4.85 PRPH - 1500 shares @ $0.5778 I’m tapped out for a couple more weeks but seeking a lot of upward movement in these small medical stocks lately.
Sold my OPTT Friday for profit & bought some ICCM.
My big play is ICCM. Hopefully they get full FDA approval in January and fly.
ICCM Good potential if they get FDA approval. I’m a very novice investor, but it seems to have some good things in the future. Like I said if the approval goes through.
$ICCM price has been very resilient this week & keeps rising.
$ICCM. Someone is trying to float crush $SMFL. Might grab a position their too.
$ICCM Their Cryoablation procedure has a 99.74% recurrence free rate for women with breast cancer. FDA approval pipeline Best of all, Japanese giant Terumo is submitting application to use their product. This might be a runner.
$ICCM Breast cancer catalyst
Check $ICCM. Might be early to the party
Anyone watching $ICCM? Looks promising with catalysts
FDA grants Icecure $ICCM marketing authentication for their device. Jump now as stock has barely moved pre market
Icecure medical $ICCM up pre market on positive results showing zero recurrence of breast cancer tumors
ICCM has some decent news. But the volume is till a little low.
Today might be your last chance to get in cheap on $ICCM. Volume is off the charts today but no sign of sell off. Company released PR regarding recent findings. They've developed a way to freeze cancer tumors rather than invasive surgery. This could be the new "standard of care" in a year
TEVA and CPRX. [ICCM](https://www.prnewswire.com/il/news-releases/study-using-icecures-prosense-treatment-results-in-100-tumor-reduction-in-early-stage-breast-cancer-302070971.html&ved=2ahUKEwiVu4vqtdSEAxVPhIkEHeFsBe0QFnoECBUQAQ&usg=AOvVaw2Igy1oGW85XlyYJpXH6rMd) will be one to watch in the coming years, they used cryoablation to eradicate cancer tumors with 100% efficacy.
ICCM - How does 100% tumor cancer cure not attract people? [https://finance.yahoo.com/news/study-using-icecures-prosense-treatment-130000481.html](https://finance.yahoo.com/news/study-using-icecures-prosense-treatment-130000481.html)
ICCM Can't believe this is not moving with great news
ICCM met with the FDA last month in Washington and presented their case. The FDA has reevaluated the new data for ProSense and make a decision in the next 6 months. The new rest data is better than expected. Nothing certain but ICCM has an excellent chance in the reopened review process.
Whats your take on FDA reopening ICCM breast cancer therapy? Shorts took over like the zombies from Z.
ICCM for long-term explosion!! Cryoablation! FDA approval is coming! 100X Bagger when final approval cones!
$ICCM https://www.prnewswire.com/news-releases/us-fda-grants-icecure-medicals-appeal-reopens-de-novo-classification-request-for-marketing-authorization-of-prosense-for-early-stage-breast-cancer-302047629.html
I hope you bought some ICCM
Jump on ICCM. 🚀🚀🚀🚀after report over the weekend
ICCM before report. Quick money maker if you’re in right.
Buy ICCM before the announcement.
Your post with title "What's happening with ICCM?" has been automatically removed from r/PennyStocks for being low-effort/spam. (Low word count) probably by u/automod *I am a bot, and this action was performed automatically. Please [contact the moderators of this subreddit](/message/compose/?to=/r/pennystocks) if you have any questions or concerns.*
Yeah....saw this pop yesterday. Wish I'd gotten in, up 18% so far, but dont wanna fomo jump in after a jump like it's had already. On my radar....as is ICCM.
Hey all! It has been a while, really happy to see this place back up! The follow is AI generated and still in active development, use it as a jumping off point and make good decisions: $HSCS TAGS: (long news) Heart Test Laboratories (HSCS) is riding a wave of positive sentiment, with a significant pre-market rise of 34% to $0.27 following a licensing agreement with the Icahn School of Medicine at Mount Sinai. The broader market indicators SPY and QQQ also lean bullish, suggesting a supportive backdrop for HSCS. However, the stock's recent candles show some volatility, with a high of $0.3085 and a low of $0.2377. Given this, I recommend a long position for today. An optimal entry point would be around $0.28, with a first price target of $0.30 and a second price target of $0.32. A stop loss should be set at $0.26 to mitigate potential losses. Confidence levels are 90% for the first target and 70% for the second target. The overall confidence in this trading strategy is 80%. $RDHL TAGS: (short news) RedHill Biopharma Ltd. (RDHL) is riding high on the FDA's five-year market exclusivity grant for its drug, Talicia, causing a significant surge in its share price. The broader market sentiment, as indicated by SPY and QQQ, leans bullish, suggesting a supportive backdrop for RDHL. However, the stock's recent sharp rise and high RSI values hint at overbought conditions, which could trigger a pullback due to profit-taking. For today's trading session, I recommend a short position. Enter at around $1.26, which is slightly above the current price of $1.15, taking advantage of any initial upward momentum. Set the first price target at $1.18 and the second at $1.10, reflecting potential downward pressure after the initial surge. Place a stop loss at $1.30 to limit potential losses if the price unexpectedly rallies. Confidence levels are 90% for the entry price, 92% for the first target, 90% for the second target, and 95% for the stop loss. $WHLR TAGS: (short) Wheeler Real Estate Investment Trust (WHLR) is in the spotlight today, with a pre-market surge of 47% to $0.2426, following a 23% decline the previous day. This volatility suggests a highly reactive market environment for WHLR, potentially driven by investor sentiment or speculative trading. The broader market sentiment from SPY and QQQ leans bullish, which could influence WHLR's price action. The stock's current price is $0.3058, with a high trading volume of 9.33M. The recent candles show a strong upward momentum, with the last candle closing at $0.3029. The 10-day SMA and 20-day EMA are below the current price, indicating a bullish trend. However, the RSI values are below 50, suggesting a potential pullback. Given the current market conditions and technical indicators, I recommend a short position for WHLR. The entry price should be around $0.31, with a first price target of $0.29 and a second price target of $0.27. The stop loss should be set at $0.32. I am 90% confident in the first price target and 80% confident in the second price target. $HKD TAGS: (long) HKD, a tech stock with a market cap of $1.05B, is showing signs of volatility, influenced by broader market sentiment reflected in Zscaler's Q1 results. The SPY and QQQ overviews suggest a bullish trend, but overbought conditions hint at potential pullbacks. HKD's recent trading activity shows a surge in buying pressure, pushing the price above its 10, 20, and 50-day SMAs and EMAs. High RSI values and positive MACD histograms reinforce this upward momentum. For today's session, I recommend a short position due to potential profit-taking after the recent rally. Enter the trade at around $5.60, confident at 92%. If the price rises, exit at the first target of $5.75 (confidence: 90%). If momentum continues, the second target is $5.90 (confidence: 91%). Set a stop loss at $5.45 to limit potential losses, confidence level at 95%. $ICCM TAGS: (long news) IceCure Medical Ltd. (ICCM) is on the radar today, with a recent study bolstering the efficacy of its ProSense® System, a promising development for this $33.78M market cap company. The broader market sentiment leans bullish, as indicated by SPY and QQQ trends, which could provide a supportive backdrop for ICCM. The stock's current price is $1.155, with a significant trading volume of 13.13M. Today's early trading shows a strong upward momentum, with the price reaching $1.265 from an opening of $0.78. Given the positive news and market sentiment, I recommend a long position. Entry at around $1.20, with a first price target of $1.30 and a second price target of $1.40, seems feasible. A stop loss at $1.10 would limit potential downside. Confidence levels are high: 95% for the entry price, 90% for the first target, and 85% for the second target.
Did anyone hear about ICCM? What do you think about this stock?
ICCM looks like something to trade
ICCM Gamma Squeeze 💎👏🚀🦍 (HODL UNTIL JAN 20th)
COSM, BBBY, AMC & ICCM. waiting on some good news with ICCM them boom boom time!!!!
ICCM.. what is the news
ICCM - solid cancer tumor results
Dose someone know something or two about ICCM stock that waiting for FDA approval for here own product about breast cancer operation ?